🔬 Mosteller, Du Bois & Haycock Formulas💊 BNF Chemotherapy & Drug Dosing Index🫘 1.73 m² eGFR Normalisation Reference🫀 Hemodynamic Cardiac Index (CI)
Body Surface Area Calculator: Accurate BSA (m²) UK Medical Guide
Use our evidence-based Body Surface Area Calculator to accurately calculate body surface area (BSA) in square metres (m²) using validated clinical equations. While standard BMI calculation compares mass to stature, calculating your body surface area by height and weight serves as the indispensable clinical gold standard across NHS hospitals for precision chemotherapy dosing, indexation of cardiac output, burn fluid resuscitation, and normalising kidney function (eGFR).
📐 Body Surface Area (BSA) Calculator UK
⚡ Quick Presets:
Mosteller FormulaClinical Grade Result
1.90 m²
Your calculated body surface area is 1.90 m². This is 110% of the standard adult reference norm (1.73 m²) used across NHS laboratories to calculate kidney filtration (eGFR).
BMI Cross-Reference
24.2 kg/m²
Healthy Weight Range
Standard eGFR Ratio
1.10 ×
Relative to 1.73 m² reference
Reference Chemo Dose
190 mg
Sample 100 mg/m² protocol
Norm Cardiac Output
5.7 L/min
Assumes CI = 3.0 L/min/m²
Formula Comparison Breakdown:
Clinical Formula
Calculated BSA
Variance
Mosteller
1.90 m²
Reference
Du Bois & Du Bois
1.89 m²
-0.5%
Haycock (Paediatric)
1.91 m²
+0.5%
Gehan & George
1.91 m²
+0.5%
Boyd (Logarithmic)
1.92 m²
+1.0%
What Is Body Surface Area (BSA) and Why Is It Medically Essential?
What is a BSA calculator? A body surface area calculator computes the total external surface area of the human body expressed in square metres (m²). While simple weight (kg) and Body Mass Index (BMI) are widely used in general public health screening, BSA has been universally recognised for over a century as a vastly superior biometric parameter for evaluating metabolic workload, basal metabolic rate (BMR), systemic fluid requirements, and the clearance of complex pharmaceuticals.
The biological rationale for body surface area lies in allometric scaling: mammalian heat exchange, basal cellular respiration, cardiac output, and renal capillary filtration rate all scale roughly proportional to surface area rather than raw volume or total weight. In a clinical context, adipose tissue (body fat) has vastly lower capillary blood flow and metabolic turnover compared to skeletal muscle, hepatic parenchyma, and renal tissue. Dosing narrow-therapeutic-index drugs purely per kilogram of body weight routinely leads to severe under-dosing in lean individuals and catastrophic toxic overdosing in overweight or obese patients.
🏥 Clinical Benchmark: The 1.73 m² Standard Human
In the 1920s, physiological pioneers determined that the average human adult possessed an approximate body surface area of 1.73 m². To this day, laboratory reports throughout the NHS and global medical systems report kidney filtration function as eGFR in mL/min/1.73 m². If your personal BSA is 2.10 m², your true individual filtration capacity is significantly higher than the standard lab printout, which is why clinical pharmacists explicitly "de-index" eGFR when prescribing narrow-index antibiotics.
To evaluate whether your overall mass falls within an optimal proportional frame alongside your surface area, you can cross-reference your results using our NHS BMI chart and our guide to healthy BMI categories explained.
How to Calculate Body Surface Area: Comparing the 5 Clinical Formulas
Because direct anatomical measurement of living human surface area (traditionally performed in early 20th-century studies by encasing subjects in gummed paper molds or plaster coatings) is clinically impossible, doctors and scientists have developed mathematical formulas to calculate body surface area using height and weight.
1. The Mosteller Formula (1987) — NHS & Global Oncology Standard
Published by Dr. Robert D. Mosteller in the New England Journal of Medicine, this formula simplifies calculations into a single square root. Due to its remarkable accuracy and minimal risk of arithmetic transcription errors, it is the standard formula embedded in UK electronic prescribing systems.
2. The Du Bois & Du Bois Formula (1916) — The Historical Baseline
Derived by Eugene and Delafield Du Bois using photographic and plaster mold measurements on nine human subjects. For nearly 70 years, it was the uncontested universal gold standard. Mosteller was specifically calibrated to mirror Du Bois outputs.
3. The Haycock Formula (1978) — Paediatric & Infant Standard
Specifically designed and validated for infants, young children, and severely malnourished paediatric patients where adult power constants overestimate surface area due to distinct infant cranial-to-torso proportions.
Gehan & George (1970) and Boyd (1935) Equations
The Gehan and George formula (BSA = 0.0235 × Ht^0.42246 × Wt^0.51456) was derived from direct surface area measurements of 401 individuals across all ages and body shapes, offering exceptional statistical robustness in clinical research. The Boyd formula incorporates a dynamic logarithmic exponent that adjusts weight scaling as total mass expands into extreme obesity (BSA = 0.0003207 × Ht^0.3 × Wt(g)^(0.7285 - 0.0188 log10(Wt(g)))).
Clinical Formula
Mathematical Equation
Primary Clinical Application
Key Strengths & Clinical Context
Mosteller (1987)
√[ (Ht × Wt) / 3600 ]
NHS Trusts, BNF, Chemotherapy
Fastest, lowest calculation error rate, identical to Du Bois within 1%
Du Bois & Du Bois (1916)
0.007184 × Ht^0.725 × Wt^0.425
Physiological Research, Cardiology
The historical benchmark against which all modern equations are validated
Haycock (1978)
0.024265 × Ht^0.3964 × Wt^0.5378
Paediatric Medicine, Neonatology
Optimal scaling for infants and children with non-adult anatomical proportions
Gehan & George (1970)
0.0235 × Ht^0.42246 × Wt^0.51456
Statistical Oncology Trials
Validated on the largest diverse autopsy/living patient cohort (n=401)
Boyd (1935)
0.0003207 × Ht^0.3 × Wt_g^(exp)
Severe Obesity Metabolic Analysis
Accounts for shifting fat-to-surface scaling at high body mass
Normal Body Surface Area Ranges in the UK: What Is an Average BSA?
Because BSA is derived from both height and weight, there is no single "target" number that defines ideal health. Rather, your expected BSA correlates directly with your stature, sex, muscularity, and adiposity. In the United Kingdom, epidemiological demographic health surveys record the following population averages:
Demographic Group
Average Height
Average Weight
Typical BSA (Mosteller)
Normal Expected Range
UK Adult Male
178 cm (5' 10")
84 kg (13 st 3 lbs)
1.98 m²
1.75 m² – 2.25 m²
UK Adult Female
162 cm (5' 4")
70 kg (11 st 0 lbs)
1.73 m²
1.50 m² – 1.95 m²
Standard Reference Human
170 cm (5' 7")
63 kg (9 st 13 lbs)
1.73 m²
Universal eGFR Normalising Baseline
Adolescent (14 Years)
160 cm (5' 3")
50 kg (7 st 12 lbs)
1.49 m²
1.30 m² – 1.70 m²
Child (10 Years)
138 cm (4' 6")
34 kg (5 st 5 lbs)
1.14 m²
0.98 m² – 1.30 m²
Child (5 Years)
110 cm (3' 7")
19 kg (3 st 0 lbs)
0.76 m²
0.68 m² – 0.85 m²
Neonate / Newborn
50 cm (1' 8")
3.5 kg (7 lbs 11 oz)
0.22 m²
0.20 m² – 0.25 m²
If your BSA is significantly higher than average due to excess body weight, calculating your ideal weight calculator UK score and reviewing our guide to a safe rate of weight loss per week can help guide healthy body composition changes without compromising lean tissue mass.
Top Clinical Applications of Body Surface Area in NHS Medicine
Why do healthcare providers routinely measure BSA instead of relying exclusively on body weight? In modern clinical medicine, body surface area serves as the primary denominator across four critical therapeutic specialties:
💊 Chemotherapy Drug Dosing
Cytotoxic agents (e.g. Cisplatin, Paclitaxel, Fluorouracil) possess steep dose-response curves. Dosing protocols are specified in mg/m² to standardise systemic drug exposure, preventing fatal haematological toxicity while ensuring adequate tumoricidal concentration.
🫘 Renal Function & eGFR
Laboratories standardise glomerular filtration rate to mL/min/1.73 m². For critically ill or non-average patients, clinicians de-index eGFR to calculate true clearance (mL/min) for dosing toxic antibiotics like Gentamicin and Vancomycin.
🫀 Hemodynamics & Cardiac Index
Cardiac output varies with body size. Cardiologists calculate Cardiac Index (CI = CO / BSA) in L/min/m² to diagnose heart failure, cardiogenic shock, and aortic stenosis severity, comparing performance across patients of wildly different statures.
🔥 Burns & Fluid Resuscitation
In acute trauma, the Lund and Browder chart and Rule of Nines estimate the percentage of Total Body Surface Area (% TBSA) burned, directly determining intravenous fluid resuscitation volumes via the Parkland and Brooke formulas.
👶 Paediatric Pharmacotherapy
Children metabolise and clear drugs at vastly higher rates per kilogram than adults. Dosing paediatric medications via BSA prevents severe under-dosing in infants and young children undergoing intensive medical therapies.
🫁 Pulmonary Function Tests
Spirometry volumes including Forced Vital Capacity (FVC) and Total Lung Capacity (TLC) correlate tightly with thoracic surface geometry. BSA normalisation ensures accurate diagnosis of restrictive and obstructive lung diseases.
Clinical Vignette: Chemotherapy Dosing Based on BSA
Consider two adult patients who both weigh exactly 90 kg:
Patient A (Tall and Muscular): 195 cm tall, 90 kg. Mosteller BSA = 2.21 m².
Patient B (Short and Adipose): 155 cm tall, 90 kg. Mosteller BSA = 1.97 m².
Under a standard oncology protocol prescribing 100 mg/m² of an intravenous antineoplastic agent, Patient A receives 221 mg, while Patient B receives 197 mg. If the oncologist had dosed by weight alone (e.g. 2.3 mg/kg), both would have received 207 mg—underdosing Patient A's high vascular volume and severely overdosing Patient B, whose adipose tissue provides minimal metabolic drug clearance.
BSA vs. BMI vs. Lean Body Mass: Understanding the Differences
While Body Surface Area (BSA), Body Mass Index (BMI), and Body Fat Percentage all utilise height and weight measurements, they answer fundamentally different clinical questions:
Biometric Metric
Measurement Units
Primary Clinical Purpose
Major Clinical Advantage
Key Limitation
Body Surface Area (BSA)
Square metres (m²)
Pharmacological dosing, eGFR indexing, cardiac index
Accurately mirrors metabolic mass and vascular blood volume
Does not assess whether weight is healthy or excessive
Body Mass Index (BMI)
kg/m² (dimensionless)
Population screening for underweight, overweight, and obesity
Important Clinical Limitations and Capping in Extreme Obesity
Despite its widespread clinical utility, calculating body surface area via standard two-variable formulas has notable limitations that healthcare teams must navigate:
The Extreme Obesity Dilemma (BSA Capping): In morbidly obese individuals (BMI > 40 kg/m²), body surface area can exceed 2.6 m² or even 3.0 m². Historically, oncologists frequently "capped" BSA at 2.0 m² out of fear of fatal drug toxicity. However, modern guidelines from the American Society of Clinical Oncology (ASCO) and the British Oncology Pharmacy Association (BOPA) recommend using actual, uncapped BSA in most curative settings, adjusting only if severe toxicity emerges.
Fluid Shifts, Ascites, and Peripheral Oedema: Severe congestive heart failure, hepatic cirrhosis with ascites, and renal nephrotic syndrome cause massive water retention. This acute fluid gain artificially inflates body weight and calculated BSA without adding functional metabolic tissue, potentially leading to overdosing.
Limb Amputations: Patients who have undergone unilateral or bilateral leg amputations have significantly less surface area than predicted by height and weight equations. In these cases, clinicians manually deduct estimated surface area percentages based on burn-surface standards (e.g. 16% for a complete lower limb).
⚠️ Important Safety Warning for Patients
This calculator is provided for clinical educational reference, training, and general health awareness. Never adjust your prescription medication doses, chemotherapy schedules, or clinical fluid regimens based on online calculation tools. Prescriptions must always be evaluated, compounded, and verified by your clinical oncologist, medical consultant, or hospital clinical pharmacist.
Frequently Asked Questions About Body Surface Area (BSA)
Body Surface Area (BSA) is the total external surface area of the human body, measured in square metres (m²). Unlike total body weight, which includes inactive fat stores, BSA scales closely with basal metabolic rate, cardiac output, systemic blood volume, and kidney filtration capacity, making it the preferred biometric index for precision medication dosing.
In the UK, the average body surface area for an adult male is approximately 1.90 m² to 1.98 m², while for an adult female it is approximately 1.60 m² to 1.73 m². A standardised value of 1.73 m² is universally used in laboratory medicine as the reference baseline for calculating kidney eGFR.
The Mosteller formula is the standard formula utilized across NHS hospital trusts, the British National Formulary (BNF), and clinical oncology guidelines. Its mathematical simplicity (square root of [height in cm × weight in kg ÷ 3600]) dramatically reduces mathematical calculation errors while delivering results within 1% of the classic Du Bois & Du Bois equation.
Chemotherapy drugs have exceptionally narrow therapeutic indices, where a tiny overdose can destroy bone marrow and a minor underdose fails to eradicate malignancy. Adipose tissue has very low blood flow and metabolic turnover. Dosing purely per kilogram of weight tends to overdose obese patients and underdose lean individuals. BSA reflects true organ clearance and blood volume far more accurately.
Larger people naturally have larger kidneys with a greater number of glomeruli. To allow clinicians to compare kidney health across patients of different statures using universal Chronic Kidney Disease (CKD) staging cut-offs (such as eGFR < 60 mL/min), laboratories mathematically standardise kidney output to a historical average adult surface area of 1.73 m².
BMI is a dimensionless ratio calculated as weight in kilograms divided by height in metres squared (kg/m²), primarily used as a general epidemiological tool to categorise underweight, healthy weight, overweight, and obesity. In contrast, BSA is a physical measurement of surface area in square metres (m²) reflecting metabolic workload, utilized for medical dosing and physiological indexation.
Explore Related Clinical Calculators & Health Guides
National Institute for Health and Care Excellence (NICE): Clinical knowledge summaries on cytotoxic drug dosing, renal function estimation, and cardiovascular risk assessment.
British National Formulary (BNF / NICE): Prescribing guidelines, body surface area calculations, and drug dosing principles in adults and paediatrics.
Mosteller, R. D. (1987): "Simplified Calculation of Body-Surface Area." New England Journal of Medicine, 317(17), 1098.
Du Bois, D. & Du Bois, E. F. (1916): "A formula to estimate the approximate surface area if height and weight be known." Archives of Internal Medicine, 17(6), 863–871.
British Oncology Pharmacy Association (BOPA): Clinical standards for cytotoxic drug dosing and verification of body surface area in clinical oncology.
UK Kidney Association & NHS England: Clinical guidance on the interpretation and de-indexation of eGFR (mL/min/1.73 m²) for therapeutic drug monitoring.
Medical Disclaimer: This Body Surface Area Calculator is designed solely for educational reference, academic training, and health information purposes. It does not constitute formal medical advice, clinical pharmacotherapy consultation, or treatment prescriptions. Dosages of cytotoxic medications, chemotherapy, and narrow-index therapeutics must always be verified and administered by qualified medical consultants, clinical oncologists, and registered hospital pharmacists. If you have personal health concerns, consult your GP or healthcare provider.